4569 |
Case 4. CT-guided CTO-PCI |
Masaaki Okutsu |
Apr. 18. 24 |
4568 |
Case 3. IVUS-Guided vs. Angiography-Guided CTO-PCI |
Gerald Werner |
Apr. 18. 24 |
4567 |
Case 2. Retrograde CTO-PCI: Tips, Tricks, and Troubleshooting |
Sandeep Basavarajaiah |
Apr. 18. 24 |
4566 |
Case 1. Antegrade CTO-PCI: Tips, Tricks, and Troubleshooting |
Jung-Kyu Han |
Apr. 18. 24 |
4565 |
What Is the Next Weapon for CTO-PCI? |
Maoto Habara |
Apr. 18. 24 |
4564 |
Reducing Complications in CTO-PCI |
Scott Harding |
Apr. 18. 24 |
4563 |
Implications of the ISCHEMIA Trial on Patient Selection for CTO-PCI |
Sripal Bangalore |
Apr. 18. 24 |
4562 |
HALT-Pathologic Underpinnings |
Aloke V. Finn |
May. 08. 23 |
4561 |
Should Jardiance be Used as 1st Essential Medication for Heart Failure, Regardless of LVEF? |
Kyung Hoon Cho |
Apr. 20. 23 |
4560 |
Jardiance, The First Successful Result for Heart Failure with Preserved Ejection Fraction |
Wonjae Lee |
Apr. 20. 23 |